Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2-, node-positive, high-risk early breast cancer in Italy.

  • Source: Global & regional health technology assessment [Glob Reg Health Technol Assess] 2023 Sep 28; Vol. 10, pp. 62-69. Date of Electronic Publication: 2023 Sep 28 (Print Publication: Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

×